One study proposes induction of DNA damage by the COX inhibitor R-flurbiprofen following the observation that R-flurbiprofen increases p53 (Ser 15) phosphorylation in colon cancer cells, but this has yet to be verified [33]. The gene discussed is TP53; the disease is colonic neoplasm.